Founded December 2013
Stage Business development
Investors The Trendlines Group, Naton Medical Group
CEO Lee Ranon
Arcuro Medical’s CEO Lee Ranon (standing) and CTO Ran Oren discuss the Company’s novel meniscus repair system.
Arcuro introduces SuperBall, the first knotless meniscus repair system for an effective, secure, reliable repair. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The Company’s novel approach is based on a technique in which the entire procedure is performed inside the joint space using suture material only and requiring just one entry into the joint.
Approved patent in United States and China; pending in Europe and Israel
Extensive managerial and business development experience; previous positions include marketing and sales director at T.A.G. Medical Products, operations and project development manager at T.A.G., European marketing and sales manager at Frutarom Industries; worldwide connections with key opinion leaders in the international sports medicine and orthopedics communities
Over 20 years’ experience in the medical device industry; founder, CEO & R&D director at T.A.G. Medical Products, products developed at T.A.G. are currently sold worldwide by J&J, Stryker, S&N, Tornier, and others; invented, developed, and commercialized numerous innovative medical devices; written 40 international patents
15 years’ experience developing medical devices; previously, design engineer and project manager, T.A.G. Medical Products, specializing in medical devices for sports medicine
15+ years’ experience in sports medicine and orthopedics industry; seasoned leader in sales, marketing, product commercialization, driving strategic growth and product visibility globally; proven track record in business development, distributor and customer management, new product introductions; Managing Director, Metrik Medical, sales and marketing consulting; previously, Ibero-America Regional Manager at Arthrex
Director of Sports Medicine, Louis A. Weiss Memorial Hospital, Center for Athletic Medicine, Chicago, Illinois
Assistant Professor, Departments of Orthopaedic Surgery (Ortho-Research) and Hospital for Joint Diseases, New York University Orthopedic Surgery Associates
Head of Sports Department, Orthopedic Surgery, Tel-Aviv Sourasky Medical Center
Black Hills Orthopedic & Spine Center, Rapid City, South Dakota
Located in the knee joint, the delicate meniscus is a C-shaped cartilage that acts as a shock absorber and “cushions” the knee. Meniscus tears can be found in professional athletes, and as much as 60% of the population over age 65.
To maintain functionality, current practice is moving away from surgical removal of the meniscus toward arthroscopic repair techniques. Shortcomings of current repair devices, however, include rigid implants, knots in the joint space, and difficult-to-use delivery systems that lead to poor repair quality, increased intraoperative failure, long-term damage to the meniscus, device failures, and the inability to repair all areas of the meniscus.
Worldwide, there are more than 2 million meniscus procedures performed annually. The global market (excluding China) is more than $300 million, with a CAGR of 13%.
Among the leading players: Arthex, ConMed, DePuy Synthes, Smith & Nephew, Zimmer.
